Looks like Qiagen is going away from 3M for their membranes to Pall. I know Pall tried to launch a kit with Beckman Coulter several years ago that kind of flopped. I suspect that Qiagen will do much better. 3M is selling their own plates now for less - I'm thinking Qiagen will do better with Pall as the market shifts more into a commodities market. Looks like they intend to use magnetics in their next phase of premium products? Did they dump their Rosys division? Interesting to see how everyone does in the proteomics/cellomics market. Seems to be a crossroads in the industry at this point.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar<